← SynDRA
BIMOSIAMOSE
SynDRA canonical compound SYN0023937 — structure-anchored drug synonym record
| Clinical phase | Phase 2 |
|---|
| Primary target(s) | ICAM1 | SELE | SELP |
|---|
| Mechanism of action | p selectin inhibitor |
|---|
| Indication | chronic obstructive pulmonary disease (copd) |
|---|
| Disease area | pulmonary |
|---|
All known targets
Mechanisms of action (all sources)
- SELL INHIBITOR
- Selectin inhibitor
- SELE INHIBITOR
- SELP INHIBITOR
- p selectin inhibitor
Cross-references
Synonyms
- Bimosiamosa
- TBC-1269
- bimosiamosa
- DTXCID4028709
- TBC1269
- bimosiamosum
- RefChem:119828
- TBC 1269
- Bimosiamose [INN]
- NCGC00183833-01
- UNII-97B5KCW80W
- BIMO
- BIMOSIAMOSE [MI]
- GTPL9049
- orb1707551
- SCHEMBL12182030
- SCHEMBL29367817
- SCHEMBL29372538
- Tox21_113260
- BDBM50324667
- C46H54O16
- MFCD00954185
- AKOS040741338
- compound 15e [PMID: 9544210]
- DA-61667
- MS-31594
- HY-106139
- CAS-187269-40-5
- CS-0024963
- NS00073447
- G12936
- T14574
- TBC-1269Z
- RefChem:119829
- HY-106139A
- Bimosiamose disodium salt
- Bimosiamose disodium [USAN]
- BIMOSIAMOSE DISODIUM SALT [MI]
Look up BIMOSIAMOSE in the interactive SynDRA portal →